Home/Filings/4/0001593968-23-001153
4//SEC Filing

Mayo Stephen 4

Accession 0001593968-23-001153

CIK 0001737287other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 4:07 PM ET

Size

4.8 KB

Accession

0001593968-23-001153

Insider Transaction Report

Form 4
Period: 2023-08-07
Mayo Stephen
Director
Transactions
  • Sale

    Common Stock

    2023-08-07$4.29/sh10,000$42,85525,328 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.27 to $4.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1
  • filerCIK 0001849061

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:07 PM ET
Size
4.8 KB